Impact on carer burden when stable patients with schizophrenia transitioned from 1-monthly to 3-monthly paliperidone palmitate
نویسندگان
چکیده
منابع مشابه
PM409. Paliperidone Palmitate 3-Monthly vs. 1-Monthly Injectable in Schizophrenia Patients with or without Prior Exposure to Oral Risperidone or Paliperidone
Objective: This study aimed to identify patient’s and primary caregiver’s factors that may affect family burden of primary caregivers targeting patients with schizophrenia and their primary caregivers and furthermore to investigate the influence of primary caregiver’s quality of life. Methods:72 schizophrenia patients and their 72 primary caregivers were investigated and sociodemographic data w...
متن کاملPM511. Determinants of Caregiver Burden in Family Carers of Asian Patients with Schizophrenia treated with Paliperidone Palmitate 3-monthly injectable
s | 85 Sub Topic(by disorder): [Attention deficit / Dimentia / Schizophrenia / (others)] Sub Topic(by methodology): [Neurophysiology / Computational Neuroscience / (others)] PM509 Homeostatic synaptic plasticity of parvalbuminpositive inhibitory interneurons confers cognitive dysfunction in medial prefrontal cortex. Jae Jin Shin1,2, Yong Gyu Kim2,3, Soo Yong Kim2,3, Joo Min Park4, and Sang Jeon...
متن کاملPM410. Comparison of 3-Monthly versus 1-Monthly Paliperidone Palmitate for Time to Onset and Time to Resolution of Extrapyramidal Symptoms in Patients with Exacerbated Schizophrenia
s | 49 Improvements in PANSS scores following OL PP1M were similar in recent RIS/PALI (mean [SD] of -18.3 [17.96]) and no prior RIS/PALI (-21.1 [16.40]) subgroups at OL endpoint. Relapse-free rates during DB phase were comparable across recent RIS/PALI (PP3M: 89.7%; PP1M: 87.1%, 95% CI for difference: [-4.7; 10.0]) and no RIS/PALI subgroups (PP3M: 91.6%; PP1M: 90.8%, 95% CI for difference: [-4....
متن کاملPM532. Symptomatic Remission and Functional Recovery after Paliperidone Palmitate 3-monthly or 1-monthly treatment in Asian Patients with Exacerbated Schizophrenia
s | 93 perception bias was associated with trait anxiety [beta=0.49, t=4.3, p<0.001, R-square=0.23, F(1,58)=18.7, p<0.001] and blame bias [F(2,56)=14.4, p<0.001] was associated with trait anxiety (beta=0.27, t=2.0, p=0.047) and low self-esteem (beta=-0.38, t=-2.9, p=0.006) in UHR individuals. Conclusion: These findings suggest that attribution bias may have been ahead of the onset of overt psyc...
متن کاملPM419. Efficacy and safety of paliperidone palmitate 3-monthly versus 1-monthly formulation in Asian patients with schizophrenia: Subgroup analysis of a randomized, double-blind, noninferiority study
Objective: This post hoc analysis evaluated the efficacy of lurasidone in patients with acute schizophrenia with prominent positive symptoms. Methods: Patient-level data were pooled from 5 similarly designed, multiregional, randomized, double-blind, placebocontrolled, 6-week studies of fixed-dose lurasidone (40, 80, 120, or 160 mg/d) in adult patients with acute schizophrenia. Patients with pro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Comprehensive Psychiatry
سال: 2021
ISSN: 0010-440X
DOI: 10.1016/j.comppsych.2021.152233